title: Dysphagia could be the first presenting symptom of telbivudine-induced myopathy.
authors.forename: S W
authors.initials: SW
authors.lastname: Lee
authors.forename: J H
authors.initials: JH
authors.lastname: Jang
authors.forename: B J
authors.initials: BJ
authors.lastname: Kim
mesh_terms: D000368:Aged; D000998:Antiviral Agents / Q000009:adverse effects; D003680:Deglutition Disorders / Q000139:chemically induced* / Q000175:diagnosis*; D005260:Female; D006801:Humans; D009135:Muscular Diseases / Q000139:chemically induced* / Q000175:diagnosis*; D000077712:Telbivudine; D013936:Thymidine / Q000009:adverse effects / Q000031:analogs & derivatives*
chemical_list: D000998:Antiviral Agents; D000077712:Telbivudine; D013936:Thymidine